ClinConnect ClinConnect Logo
Search / Trial NCT03479190

Platelet Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome (HiPPO Trial)

Launched by NORTHUMBRIA HEALTHCARE NHS FOUNDATION TRUST · Mar 20, 2018

Trial Information

Current as of May 15, 2025

Completed

Keywords

ClinConnect Summary

1. What is the problem being addressed? Greater trochanteric pain syndrome (GTPS), also known as trochanteric bursitis, is a painful condition characterised by pain around the greater trochanter usually affecting middle aged women (1). It was first described, as trochanteric bursitis in 1958 (2). Further details on the clinical symptoms published in 1978 as pain over the greater trochanter on walking, squatting or climbing stairs and pain on lying on the affected side or when crossing one's legs (3). Little described tenderness over the greater trochanter over the insertion of the gluteus t...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Over 18 years of age
  • 2. Symptoms consistent with GTPS present for at least 6 months
  • 3. Radiological diagnosis of GTPS using MRI, or ultrasound scan if MRI contraindicated
  • 4. Failed conservative management in any other care setting
  • 5. Patient is willing and able to provide written informed consent.
  • Exclusion Criteria:
  • 1. Lacks capacity to provide consent
  • 2. Has hip joint osteoarthritis requiring treatment on a plain radiograph
  • 3. Presence of confounding pathologies of the hip MRI
  • 4. Any extensive surgery or deformity of the hip on X-ray.
  • 5. Presence of systemic disorders -coagulopathy, active infection, immune system disorders, peripheral neuropathy, malignancy, unresolved fractures.
  • 6. Had any surgical treatment specifically targeted at GTPS e.g. bursectomy/Ilio-tibial band lengthening
  • 7. Pregnancy
  • 8. Anti-coagulant therapy eg warfarin, rivaroxaban, apixaban, dabigatran
  • 9. Haemaglobin \<10g/dL or platelets \< 150,000/ul
  • 10. Unable to safely stop anti-platelet/NSAID medications eg. Recent cardiac stenting
  • 11. Has lumbar-sacral spine pathology or a recent history of acute hip trauma
  • 12. Has a recent history of acute sciatica
  • 13. Is not able to attend or comply with treatment or follow-up scheduling
  • 14. Participates in any other clinical trial

About Northumbria Healthcare Nhs Foundation Trust

Northumbria Healthcare NHS Foundation Trust is a leading healthcare provider in the North East of England, renowned for its commitment to delivering high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, the Trust actively engages in innovative research initiatives aimed at improving health outcomes and enhancing treatment options across a range of medical disciplines. With a robust framework for clinical governance and a multidisciplinary team of experienced professionals, Northumbria Healthcare focuses on fostering collaborative partnerships to drive evidence-based practices and contribute to the broader scientific community.

Locations

Newcastle Upon Tyne, Tyne And Wear, United Kingdom

Patients applied

0 patients applied

Trial Officials

Ajay Malviya

Principal Investigator

Northumbria Healthcare NHS Trust

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials